Thromb Haemost 1997; 77(06): 1179-1181
DOI: 10.1055/s-0038-1656134
Platelets
Schattauer GmbH Stuttgart

The Leu33/Pro Polymorphism (PIA1/PIA2 ) of the Glycoprotein IIIa (GPIIIa) Receptor Is Not Related to Myocardial Infarction in the ECTIM Study

Authors

  • Stefan-Martin Herrmann

    The Institut National de la Santé et de la Recherche Médicale (Inserm) SC7, Paris
  • Odette Poirier

    The Institut National de la Santé et de la Recherche Médicale (Inserm) SC7, Paris
  • Pedro Marques-Vidal

    1   Monica Project Toulouse, France
  • Alun Evans

    2   Monica Project Belfast, Northern Ireland, UK
  • Dominique Arveiler

    3   Monica Project Strasbourg, Paris, France
  • Gerald Luc

    4   Monica Project Lille, Paris, France
  • Joseph Emmerich

    5   Hôpital Broussais, Paris, France
  • François Cambien

    The Institut National de la Santé et de la Recherche Médicale (Inserm) SC7, Paris
Further Information

Publication History

Received 25 October 1996

Accepted after resubmisssion 12 February 1997

Publication Date:
26 July 2018 (online)

Preview

Summary

The GPIIb/IIIa receptor complex may contribute to acute coronary syndromes by mediating platelet aggregation. The Leu33/Pro polymorphism (PlAl/PlA2) of the GPIIIa has recently been shown to be associated with CHD in a small case-control study. We have investigated this polymorphism in a large multicenter study of patients with myocardial infarction and controls and found no difference in the distribution of allele and genotype frequencies between cases and controls.